Data / Form D filings / View Point Medical, Inc.
View Point Medical, Inc.: Form D filings
View Point Medical, Inc., a biotechnology company in Carlsbad, CA, filed 7 Form D notices with the SEC between 2019 and 2024. The latest, on January 23, 2024, reports $3.8 million sold of a $7 million offering to 23 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 6451 EL CAMINO REAL, Carlsbad, CA, 92009
- Phone
- (858) 847-9446
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1783986
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 23, 2024 | New notice | $7,000,000 | $3,758,000 | $3,242,000 | 23 | Jan 19, 2024 | sec.gov |
| Jun 7, 2023 | Amendment | $28,708,168 | $26,230,156 | $2,478,012 | 63 | Jul 24, 2019 | sec.gov |
| Feb 23, 2023 | Amendment | $28,708,168 | $24,364,620 | $4,343,548 | 58 | Jul 24, 2019 | sec.gov |
| Feb 23, 2022 | Amendment | $25,748,657 | $21,043,520 | $4,705,137 | 45 | Jul 24, 2019 | sec.gov |
| Jan 5, 2022 | Amendment | $25,748,657 | $20,543,521 | $5,205,136 | 44 | Jul 24, 2019 | sec.gov |
| Dec 28, 2020 | Amendment | $17,159,016 | $15,084,010 | $2,075,006 | 40 | Jul 24, 2019 | sec.gov |
| Jul 31, 2019 | New notice | $12,659,036 | $9,684,021 | $2,975,015 | 32 | Jul 24, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Josh Baltzell | Director | |
| William Blair | Executive Officer, Director | |
| Peter Klemm | Executive Officer, Director | |
| Jeffrey Port | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jan 22, 2024 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what View Point Medical, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.